摘要
脱氢枞酸与二氯亚砜反应得到脱氢枞酸酰氯,再与氨基硫脲反应制备脱氢枞基氨基硫脲,脱氢枞基氨基硫脲再与芳香醛和乙酰乙酸乙酯反应,合成了10个脱氢枞酸酰胺基-3,4-二氢嘧啶酮衍生物,分别为:4-苯基-6-甲基-1-脱氢枞酸酰胺基-3,4-二氢嘧啶-2-硫酮(3a)、4-(4-甲氧基苯基)-6-甲基-1-脱氢枞酸酰胺基-3,4-二氢嘧啶-2-硫酮(3b)、4-(2-甲氧基苯基)-6-甲基-1-脱氢枞酸酰胺基-3,4-二氢嘧啶-2-硫酮(3c)、4-(4-甲基苯基)-6-甲基-1-脱氢枞酸酰胺基-3,4-二氢嘧啶-2-硫酮(3d)、4-(4-溴苯基)-6-甲基-1-脱氢枞酸酰胺基-3,4-二氢嘧啶-2-硫酮(3e)、4-(4-对三氟甲基苯基)-6-甲基-1-脱氢枞酸酰胺基-3,4-二氢嘧啶-2-硫酮(3f)、4-(4-氯苯基)-6-甲基-1-脱氢枞酸酰胺基-3,4-二氢嘧啶-2-硫酮(3g)、4-(2,6-二氯苯基)-6-甲基-1-脱氢枞酸酰胺基-3,4-二氢嘧啶-2-硫酮(3h)、4-(2-硝基苯基)-6-甲基-1-脱氢枞酸酰胺基-3,4-二氢嘧啶-2-硫酮(3i)、4-(3-硝基苯基)-6-甲基-1-脱氢枞酸酰胺基-3,4-二氢嘧啶-2-硫酮(3j)。通过FT-IR、MS、~1H NMR和~(13)C NMR表征了目标化合物结构。选取猴胚胎肾细胞MA-104作为受试细胞,测试了化合物3a~3j的细胞毒性;利用四甲基偶氮唑蓝(MTT)比色法测试了这些化合物对单纯疱疹病毒Ⅰ型(HSV-1)的体外抗病毒活性。数据显示,该系列衍生物的细胞毒性较小,与阳性对照药物利巴韦林相比,化合物3a、3b、3d、3e、3h、3i和3j体现出更小的细胞毒性;化合物3j具有较好的抑制HSV-1活性,半数抑制浓度(IC_(50))0.465 g/L,选择指数(SI)12.18,达到与阳性对照药物利巴韦林相近的抑制活性(IC_(50)为0.156 g/L,SI为12.6),其余样品具有较弱的抑制HSV-1活性。
Dehydroabietic acid chloride was prepared via the reaction of dehydroabietic acid and thionylchloride, dehydroabietic acid acylthiosemicarbazide was synthesized by thiosemicarbazone and dehydroabietic acid chloride, followed by the reaction of dehydroabietic acid acylthiosemicarbazide, aromatic aldehydes with ethyl acetate to obtain ten dehydroabietic acid amide derived 3,4-dihydropyrimidinones: 4-phenyl-6-methyl-1-dehydroabietic acid amide-3,4-dihydropyrimidine-2-thione(3 a), 4-(4-methoxyphenyl)-6-methyl-1-dehydroabietic acid amide-3,4-di-hydropyrimidine-2-thione(3 b), 4-(2-methoxyphenyl)-6-methyl-1-dehydroabietic acid amide-3,4-dihydropyrimi-dine-2-thione(3 c), 4-(4-methylphenyl)-6-methyl-1-dehydroabietic acid amide-3,4-dihydropyrimidine-2-thione(3 d), 4-(4-bromophenyl)-6-methyl-1-dehydroabietic acid amide-3,4-dihydropyrimidine-2-thione(3 e), 4-(4-p-tri-fluoromethylphenyl)-6-methyl-1-dehydroabietic acid amide-3,4-dihydropyrimidine-2-thione(3 f). 4-(4-chlorophen-yl)-6-methyl-1-dehydroabietic acid amide-3,4-dihydropyrimidine-2-thione(3 g), 4-(2,6-dichlorophenyl)-6-methyl-1-dehydroabietic acid amide-3,4-dihydropyrimidine-2-thione(3 h), 4-(2-nitrophenyl)-6-methyl-1-dehydroabietic acid amide-3,4-dihydropyrimidine-2-thione(3 i), 4-(3-nitrophenyl)-6-methyl-1-dehydroabietic acid amide-3,4-di-hydropyrimidine-2-thione(3 j).The target compounds were characterized by FT-IR, MS, ~1H NMR and ~(13)C NMR. The cytotoxicity of these 3,4-dihydropyrimidinone derivatives(compounds 3 a-3 j) were tested with monkey embryonic kidney cells(MA-104 cells). The antiviral activities against the Herpes simplex virus type I(HSV-1) of these derivatives were further evaluated with methyl thiazolyl tetrazolium(MTT) method. The results indicated that the cytotoxicity of these derivatives kept in a low level, compounds 3 a,3 b,3 d,3 e,3 h,3 i and 3 j showed lower cytotoxicity than the drug ribavirin; compound 3 j performed better inhibitory activity of HSV-1(50% inhibitory concentration(IC_(50)) 0.465 g/L,selective index(SI)12.18) which was similar to ribavirin(IC_(50)=0.156 g/L,SI=12.6),and the other compounds showed weak inhibitory activity of HSV-1.
引文
[1]罗云龙,沈明贵,王丹,等.脱氢枞酸及其衍生物生物活性的研究进展[J].化学通报,2018,81(2):122-128.LUO Y L,SHEN M G,WANG D,et al.Progress in bioactivities of dehydroabietic acid and its derivatives[J].Chemistry,2018,81(2):122-128.
[2]AKHAJA T N,RAVAL J P.1,3-Dihydro-2H-indol-2-ones derivatives:Design,synthesis,in vitro antibacterial,antifungal and antitubercular study[J].European Journal of Medicinal Chemistry,2011,46:5573-5579.
[3]ISMAILI L,NADARADJANE A,NICOD L,et al.Synthesis and antioxidant activity evaluation of new hexahydropyrimido[5,4-c] quinoline-2,5-diones and 2-thioxohexahydropyrimido[5,4-c]quinoline-5-ones obtained by Biginelli reaction in two steps[J].European Journal of Medicinal Chemistry,2008,43:1270-1275.
[4]CHIANG A N,VALDERRAMOS J C,BALACHANDRAN R,et al.Select pyrimidinones inhibit the propagation of the malarial parasite,plasmodium falciparum[J].Bioorganic & Medicinal Chemistry,2009,17:1527-1533.
[5]PROKOPCOV H,DALLINGER D,GEORG U,et al.Structure-activity relationships and molecular docking of novel dihydropyrimidine-based mitotic eg5 inhibitors[J].Journal of Medicinal Chemistry,2010,5:1760-1769.
[6]KIM J,PARK C,OK T,et al.A novel 3,4-dihydropyrimidin-2(1H)-one:HIV-1 replication inhibitors with improved metabolic stability[J].Bioorganic & Medicinal Chemistry Letters,2012,22:2522-2526.
[7]HE Y P,LONG J,ZHANG S S,et al.Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl- cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents[J].Bioorganic & Medicinal Chemistry Letters,2011,21:694-697.
[8]CHIKHALE R V,BHOL R P,KHEDEKAR P B,et al.Synthesis and pharmacological investigation of 3-(substituted 1-phenylethanone)- 4-(substituted phenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylates[J].European Journal of Medicinal Chemistry,2009,44:3645-3653.
[9]HALBROOK N J,LAWRENCE R V.The isolation of dehydroabietic acid from disproportionated rosin[J].The Journal of Organic Chemistry,1966,31(12):4246-4247.
[10]邹沐平,董栋,王怀玲,等.琼枝麒麟菜多糖抗呼吸道病毒活性研究[J].海洋科学,2015,39(12):15-20.ZOU M P,DONG D,WANG H L,et al.The anti-respiratory virus activity study ofeucheuma gelatinae polysaccharide[J].Marine Sciences,2015,39(12):15-20.